Long-term Impact of Respiratory Viral Infection After Pediatric Lung Transplantation
Overview
Authors
Affiliations
To evaluate the epidemiology and to investigate the impact of RVI on chronic allograft rejection after pediatric lung transplantation, a retrospective study of pediatric lung transplant recipients from 2002 to 2007 was conducted. Association between RVI and continuous and categorical risk factors was assessed using Wilcoxon rank-sum tests and Fisher's exact tests, respectively. Association between risk factors and outcomes were assessed using Cox proportional hazards models. Fifty-five subjects were followed for a mean of 674 days (range 14-1790). Twenty-eight (51%) developed 51 RVI at a median of 144 days post-transplant (mean 246; range 1-1276); 41% of infections were diagnosed within 90 days. Twenty-five subjects developed 39 LRI, and eight subjects had 11 URI. Organisms recovered included rhinovirus (n = 14), adenovirus (n = 10), parainfluenza (n = 10), influenza (n = 5), and RSV (n = 4). Three subjects expired secondary to their RVI (two adenovirus, one RSV). Younger age and prior CMV infection were risks for RVI (HR 2.4 95% CI 1.1-5.3 and 17.0; 3.0-96.2, respectively). RVI was not associated with the development of chronic allograft rejection (p = 0.25) or death during the study period. RVI occurs in the majority of pediatric lung transplant recipients, but was not associated with mortality or chronic allograft rejection.
Antiviral Therapeutics in Pediatric Transplant Recipients.
Otto W, Green A Infect Dis Clin North Am. 2022; 36(1):125-146.
PMID: 35168706 PMC: 8900721. DOI: 10.1016/j.idc.2021.11.004.
Epidemiology and persistence of rhinovirus in pediatric lung transplantation.
Ammerman E, Sweet S, Storch G, Buller R, Mason S, Conrad C Transpl Infect Dis. 2020; 22(6):e13422.
PMID: 32686323 PMC: 7900771. DOI: 10.1111/tid.13422.
A Mini-Review of Adverse Lung Transplant Outcomes Associated With Respiratory Viruses.
Bailey E, Zemke J, Choi J, Gray G Front Immunol. 2020; 10:2861.
PMID: 31921130 PMC: 6930876. DOI: 10.3389/fimmu.2019.02861.
Gualdoni G, Mayer K, Kapsch A, Kreuzberg K, Puck A, Kienzl P Proc Natl Acad Sci U S A. 2018; 115(30):E7158-E7165.
PMID: 29987044 PMC: 6065033. DOI: 10.1073/pnas.1800525115.
Danziger-Isakov L, Steinbach W, Paulsen G, Munoz F, Sweet L, Green M J Pediatric Infect Dis Soc. 2018; 8(3):197-204.
PMID: 29538674 PMC: 7107524. DOI: 10.1093/jpids/piy024.